Research Assistant
Search across all peptide monographs, dosing protocols, and clinical articles. Type a keyword to find relevant information instantly.
70 items available — type to search
AOD-9604
Growth Hormone Fragment - Fat Metabolism Guide
BPC-157
Body Protection Compound - Complete Clinical Guide
CJC-1295/Ipamorelin
Growth Hormone Secretagogue Combination - Prescriber Guide
Epithalon
Telomerase Activator Peptide - Anti-Aging Guide
GHK-Cu
Copper Peptide Complex - Regenerative Medicine Guide
MOTs-C
Flagship clinician reference on MOTs-C, covering mechanism, evidence limits, metabolic signaling, and the April 2026 FDA update.
PT-141 (Bremelanotide)
Melanocortin Receptor Agonist - Sexual Dysfunction Guide
Selank
Synthetic tuftsin-analog heptapeptide with anxiolytic, nootropic, and immunomodulatory properties
Semaglutide
GLP-1 Receptor Agonist - Prescriber Reference
Sermorelin
Synthetic GHRH(1-29) fragment for physiologic growth hormone optimization
TB-500
Thymosin Beta-4 Fragment - Tissue Repair Guide
Tesamorelin
GHRH Analog - FDA-Approved Growth Hormone Secretagogue
Thymosin Alpha-1
Immune-Modulating Peptide - Clinical Monograph
Tirzepatide
Dual GIP/GLP-1 Receptor Agonist - Clinical Guide
5-Amino-1MQ
Investigational metabolic and adipose-targeting agent for obesity, adipose-tissue dysfunction, and related metabolic conditions (no FDA-approved indication; no registered human clinical trials as of April 2026)
Cerebrolysin
Neurorehabilitation after ischemic stroke and traumatic brain injury (approved in 35+ countries including Austria, Germany, Russia, China; NOT FDA-approved in the United States)
Kisspeptin-10
Investigational stimulation of the hypothalamic-pituitary-gonadal (HPG) axis: diagnostic evaluation of hypogonadotropic hypogonadism, research in fertility induction, and adjunct investigation alongside testosterone replacement therapy (not FDA-approved for any indication)
KPV
Investigational anti-inflammatory therapy for inflammatory bowel disease and other chronic inflammatory conditions (no FDA-approved indication)
NAD+
Cellular energetics and mitochondrial support in age-related decline, metabolic dysfunction, and post-exertional recovery (all investigational; no FDA-approved indication for injectable NAD+)
Retatrutide
Chronic weight management and type 2 diabetes (investigational; Phase 3 TRIUMPH program ongoing. NOT FDA-approved as of April 2026)
AOD-9604 — Fat loss / Body composition
Fat loss / Body composition
BPC-157 — Gut healing
Gut healing
BPC-157 — Injury repair / Musculoskeletal
Injury repair / Musculoskeletal
Ipamorelin/CJC-1295 — Anti-aging / GH optimization
Anti-aging / GH optimization
PT-141 (Bremelanotide) — Sexual dysfunction
Sexual dysfunction
Semaglutide — Weight loss / Obesity
Weight loss / Obesity
TB-500 — Tissue repair / Wound healing
Tissue repair / Wound healing
Tesamorelin — Lipodystrophy / Visceral fat reduction
Lipodystrophy / Visceral fat reduction
When Peptide Dose Escalation Makes Sense
Raise peptide doses only after adequate time, measurable partial response, acceptable side effects, and verified adherence.
Liraglutide and GLUT4: Muscle Glucose Uptake
Preclinical data suggest GLP-1 agonists enhance GLUT4 trafficking in insulin-resistant muscle, yet direct human muscle evidence is lacking.
7 Studies on Epitalon, Aging, and Telomeres
Review finds strong cell-level effects, mixed animal results, and weak human evidence—Epitalon remains investigational.
Brown Fat Activation Peptides: 4 Mechanisms
Four peptide-linked routes to activate brown fat - UCP1, mitochondrial heat, browning, and endocrine crosstalk - with modest clinical impact.
Counterfeit Peptides: Risk Review for Prescribers
Guidance for clinicians to verify peptide sources, confirm CoA/sterility, document lots, and stop use when records are missing.
GLP-1 Peptides and Insulin-Mediated Glucose Uptake
GLP‑1 peptides lower glucose mainly via glucose‑dependent insulin, glucagon suppression, and slower gastric emptying; direct muscle uptake in humans is limited.
How to Interpret Peptide Research for Clinical Use
Clinical guide to evaluate peptide evidence, regulatory status, safety, dosing, and sourcing for responsible patient use.
Best Practices for Intramuscular Injection Angles
Practical guide to true 90° IM insertion, correct needle length, site landmarks, Z‑track, and special-population adjustments.
Oxytocin Dosing for Social Impairments
Oxytocin dosing must be matched to patient and study design; 24 IU is the common benchmark, 48 IU shows pooled benefit, and sodium monitoring is essential.
How Peptides Target Cardiovascular Tissues
How peptides plus carrier systems concentrate drugs in heart or vessel lesions—benefits, limits, safety, and clinical checks.
Peptides for Sleep and Brain Recovery: Clinical Insights
Most peptides lack robust human sleep data; approved sleep drugs lead, while Cerebrolysin shows trial evidence but remains investigational.
Regulatory Guidelines for Adverse Event Logs
How peptide clinics should log, classify, escalate, and report adverse events to meet FDA timelines and retain records for 10 years.
Tumor-Targeting Peptides: Mechanisms of Action
How tumor-targeting peptides locate tumors, cross barriers, enter cells, and act via targeting, microenvironment activation, trafficking, or drug delivery.
Bioactive Peptides in Lipid Regulation: Key Insights
Review of soy, marine, algae, and animal peptides for cholesterol, triglyceride, and liver-fat control; soy has strongest clinical evidence.
Niche Branding for Regenerative Medicine Clinics
Brand around one patient problem—not a peptide—to improve clarity, ad compliance, patient trust, and recurring revenue.
Common Drug Interactions in Weight Loss Peptides
Peptide weight-loss drugs slow gastric emptying; watch hypoglycemia with diabetes meds, reduced oral contraceptive effect, and thyroid/INR shifts.
Endotoxin Testing Regulations: What Prescribers Need to Know
How prescribers should verify endotoxin limits, COA data, and pharmacy type (503A/503B) before using compounded injectable peptides.
Top 5 Tools for Peptide Batch Calculations
Compare five essential tools for precise peptide reconstitution and dosing: clinical calculators, spreadsheets, apps, pharma tools, and syringe converters.
How Peptides Affect Appetite and Satiety Signals
How gut peptides communicate with the brain to drive hunger and fullness, and how peptide therapies alter appetite and support weight loss.
Peptide Dosing Protocols for Post-Surgery Healing
Guidelines for using BPC-157 and TB-500 after surgery: timing, dosing, safety, and monitoring.
Peptide Delivery Systems: Skin-Specific Innovations
Compare liposomes, hydrogels, microneedles and iontophoresis for safe, targeted peptide delivery across the skin barrier.
Peptide Reconstitution Errors: Causes and Fixes
Avoid peptide dosing, solvent, technique, and storage errors with clear reconstitution steps, calculators, and SOP tips.
Peptides for Brain Fog: Mechanisms of Action
Explains how peptides relieve brain fog via anti-inflammatory, mitochondrial, neurotransmitter and vascular mechanisms, plus delivery and safety.
Peptide Dosing: Avoiding GI Side Effects
Start low, titrate slowly, and use diet and hydration to prevent nausea, diarrhea, and constipation during peptide therapy.
Top 7 Trends in Sustainable Peptide Manufacturing
Seven practical trends—renewable materials, greener solvents, energy-efficient synthesis, safer chemistries, and AI—cutting waste in peptide production.
Lab Tests for Evaluating Peptide Therapy Results
Baseline, follow-up, and periodic labs (IGF-1, CMP, CBC, glucose) to safely monitor and adjust peptide therapy.
AI in Peptide Therapy: Benefits and Challenges
How AI speeds peptide therapy research, dosing, and risk checks—boosting efficiency while requiring clinician verification and regulatory vigilance.
Chondroinductive Peptides: Clinical Applications
Overview of chondroinductive peptides for cartilage regeneration: mechanisms, delivery strategies, clinical trials, and translational hurdles.
Emerging Gut-Brain Peptides for Obesity
Overview of multi-agonist gut-brain peptide therapies for obesity, including trial outcomes, mechanisms, and safety considerations.
Ultimate Guide to Peptide Therapy Conferences
Practical guide to choosing, preparing for, and applying insights from peptide therapy conferences for clinicians and researchers.
How to Build a Peptide Protocol for Metabolic Patients
Clinician-led steps to select, dose, monitor, and combine peptides for obesity, type 2 diabetes, and metabolic syndrome.
Peptide Therapy FAQs: Answers for Licensed Prescribers
Practical FAQ for licensed prescribers on patient selection, dosing, safety, and FDA compounding rules for peptide therapy.
Top Peptide Research Updates for Clinicians: 2026 Roundup
2026 clinical summary of peptide advances across weight loss, regeneration, cognition, aesthetics, and immunomodulation.
CJC-1295 vs Ipamorelin: Which GHRH Protocol Fits Best?
Pairing a short-acting GHRH analogue with a ghrelin agonist yields physiological GH pulses that boost recovery, sleep, and body composition.
Peptide Therapy Prescribing Checklist for New Clinicians
Clear checklist for clinicians covering patient evaluation, labs, legal sourcing, dosing, and monitoring of peptide therapies.
Compounded Peptides: Navigating FDA Compliance in 2026
2026 FDA updates tighten rules for compounded peptides: clinical-need documentation, 503A/503B limits, API sourcing, and PCAC reviews.
How to Counsel Patients on Peptide Injection Technique
Practical guidance on safe peptide injections: dosing math, reconstitution, storage, site rotation, and sharps disposal.
Semaglutide vs Tirzepatide: Clinical Comparison for Prescribers
Two weekly incretin therapies differ in weight, glycemic control, and long-term safety—prescribe based on cardio‑renal needs vs maximal weight loss.
8 Peptide Therapies Gaining Traction in Functional Medicine
Overview of eight peptides used in functional medicine: mechanisms, uses, dosing, and safety considerations.
Understanding Peptide Therapy: A Clinical Overview for Prescribers
A comprehensive introduction to peptide therapeutics, their mechanisms of action, and clinical considerations for integration into practice.
Regulatory Landscape: What Prescribers Need to Know About Compounded Peptides
Navigate the complex regulatory environment surrounding compounded peptides, including FDA guidelines, state requirements, and best practices for compliance.
Patient Selection Criteria for Peptide Therapy
Evidence-based guidance on identifying appropriate candidates for peptide therapeutics, including assessment protocols and contraindication screening.
Medical Disclaimer
This search tool is provided as an educational resource for healthcare professionals. Search results are drawn from curated clinical content and should not replace professional medical judgment. Always verify information with primary sources and current clinical guidelines.